Skip to main content
Year archive

Navamedic — 2025 filings

All 88 regulatory filings released by Navamedic (NAVA) in 2025, sourced directly from the official regulator.

88 Filings
2025 Period
2025 filings (88)
Filing Released Lang
Grete Roede og Navamedic lanserer nytt vektreduksjonskonsept: Lettere steg
Regulatory Filings
2025-12-29 Norwegian
Financial calendar
Report Publication Announcement
2025-12-18 English
Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026 - Attachment: NAVA_Notice_of_EGM_12_December_2025.pdf
Proxy Solicitation & Information Statement
2025-12-12 Norwegian
Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026
Proxy Solicitation & Information Statement
2025-12-12 English
Oslo, December 9, 2025 - Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson's Care with Simplified and Precise Dosing for Personalized Treatment
Regulatory Filings
2025-12-09 English
Navamedic ASA: Appointment of CFO - Attachment: NAVA_Stock_exchange_announcement_08122025.pdf
Board/Management Information
2025-12-08 English
Navamedic ASA: Utnevnelse av Finansdirektør - Attachment: NAVA_Stock_exchange_announcement_08122025_norsk.pdf
Board/Management Information
2025-12-08 Norwegian
Navamedic ASA: Appointment of CFO
Board/Management Information
2025-12-08 English
Navamedic ASA: Utnevnelse av Finansdirektør
Board/Management Information
2025-12-08 Norwegian
Navamedic ASA: Double digit growth in the 3rd quarter, 2025 - Attachment: Navamedic_Q3_2025_Presentation.pdf
Investor Presentation
2025-10-28 English
Navamedic ASA: Tosifret vekst i tredje kvartal 2025 - Attachment: Navamedic_Q3_2025_Presentation.pdf
Investor Presentation
2025-10-28 English
Navamedic ASA: Double digit growth in the 3rd quarter, 2025
Earnings Release Q3 2025
2025-10-28 English
Navamedic ASA: Tosifret vekst i tredje kvartal 2025
Earnings Release Q3 2025
2025-10-28 Norwegian
Navamedic ASA: Invitation to 2025 3rd quarter presentation
Report Publication Announcement
2025-10-24 English
Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical
Regulatory Filings
2025-10-17 English
NOTIFICATION OF MAJOR HOLDINGS - Attachment: 2025-10-15_major_shareholder_disclosure.pdf
Major Shareholding Notification
2025-10-15 English
NOTIFICATION OF MAJOR HOLDINGS
Major Shareholding Notification
2025-10-15 English
Flaggemelding NAVA
Major Shareholding Notification
2025-10-14 Norwegian
Navamedic ASA - New share capital registered
Share Issue/Capital Change
2025-10-13 English
Notification of major shareholding
Major Shareholding Notification
2025-10-07 English
Navamedic ASA: Allocation of shares in the rights issue to primary insiders and their close associates - Attachment: NAVA_Transaction_details.pdf
Director's Dealing
2025-10-07 English
Navamedic ASA: Allocation of shares in the rights issue to primary insiders and their close associates
Director's Dealing
2025-10-07 English
Navamedic ASA: Final results of the rights issue
Capital/Financing Update
2025-10-07 English
Navamedic ASA: Preliminary results of the rights issue
Capital/Financing Update
2025-10-06 English
Flaggemelding
Major Shareholding Notification
2025-10-06 Norwegian
Navamedic ASA: Mandatory notification of trades by primary insiders and their close associates - Attachment: Subscription_details.pdf
Director's Dealing
2025-10-03 English
Navamedic ASA: Mandatory notification of trades by primary insiders and their close associates
Director's Dealing
2025-10-03 English
Navamedic ASA: Last day of trading in subscription rights
Capital/Financing Update
2025-09-30 English
Navamedic ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates - Attachment: NAVA_PDRM_receipt_of_subscription_rights.pdf
Director's Dealing
2025-09-22 English
Navamedic ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates
Director's Dealing
2025-09-22 English
Navamedic ASA: Commencement of the subscription period for the rights issue
Share Issue/Capital Change
2025-09-22 English
Navamedic ASA: Approval and publication of prospectus
Capital/Financing Update
2025-09-19 English
Flaggemelding
Major Shareholding Notification
2025-08-28 Norwegian
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025 - Attachment: Navamedic_Q2_H1_2025_presentation.pdf
Investor Presentation
2025-08-14 English
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025 - Attachment: Navamedic_Q2_H1_2025_presentation.pdf
Investor Presentation
2025-08-14 English
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025 - Attachment: Navamedic_ASA_Q2_H1_2025_report.pdf
Interim / Quarterly Report H1 2025
2025-08-14 English
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025 - Attachment: Navamedic_ASA_Q2_H1_2025_report.pdf
Interim / Quarterly Report H1 2025
2025-08-14 English
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025
Earnings Release H1 2025
2025-08-14 Norwegian
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025
Earnings Release H1 2025
2025-08-14 English
Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries.
Regulatory Filings
2025-08-13 English
Navamedic ASA: Invitation to 2025 2nd quarter presentation
Report Publication Announcement
2025-08-11 English
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
M&A Activity
2025-07-15 English
Navamedic ASA: Ex. subscription rights today
Capital/Financing Update
2025-07-15 English
Navamedic ASA - Minutes of Extraordinary General Meeting - Attachment: Navamedic_ASA_Minutes_of_EGM_07_14_2025.pdf
AGM Information
2025-07-14 Norwegian
Navamedic ASA - Minutes of Extraordinary General Meeting
AGM Information
2025-07-14 English
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_JD.pdf
Director's Dealing
2025-07-11 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing
2025-07-11 English
Navamedic ASA: Updated key information relating to the rights issue
Capital/Financing Update
2025-07-10 English
Navamedic ASA - Additional underwriting commitments in the Rights Issue
Capital/Financing Update
2025-06-29 English
Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product
Regulatory Filings
2025-06-27 English
Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS - Attachment: Navamedic_Investor_Presentation_June_24_2025.pdf
Investor Presentation
2025-06-24 English
Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS
M&A Activity
2025-06-24 English
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_Primary_insider.pdf
Director's Dealing
2025-06-23 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing
2025-06-23 English
Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in connection with a contemplated rights issue - Attachment: NAVA_Notice_of_EGM_July_14_2025.pdf
AGM Information
2025-06-23 Norwegian
Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in connection with a contemplated rights issue
AGM Information
2025-06-23 English
Navamedic ASA: Key information relating to the Rights Issue
Capital/Financing Update
2025-06-23 English
Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue
Share Issue/Capital Change
2025-06-23 English
Navamedic ASA: Minutes of Annual General Meeting - Attachment: Navamedic_Minutes_of_AGM_2025.pdf
AGM Information
2025-06-04 Norwegian
Navamedic ASA: Minutes of Annual General Meeting
AGM Information
2025-06-04 English
Navamedic ASA: Notice of Annual General Meeting
AGM Information
2025-05-14 Norwegian
Navamedic ASA: Notice of Annual General Meeting
AGM Information
2025-05-14 English
Navamedic ASA launches Eroxon® in Denmark
Regulatory Filings
2025-05-05 English
Navamedic ASA: Annual Report 2024
Annual Report FY 2024
2025-04-30 English
Navamedic ASA: Annual Report 2024
Annual Report FY 2024
2025-04-30 English
Navamedic ASA: Annual Report 2024
Report Publication Announcement
2025-04-30 English
Navamedic Q1 2025: Sterk start på året og godt posisjonert for fremtidig vekst
Interim / Quarterly Report Q1 2025
2025-04-30 English
Navamedic Q1 2025: Strong start of the year and well-positioned for future growth
Interim / Quarterly Report Q1 2025
2025-04-30 English
Navamedic Q1 2025: Sterk start på året og godt posisjonert for fremtidig vekst
Earnings Release Q1 2025
2025-04-30 Norwegian
Navamedic Q1 2025: Strong start of the year and well-positioned for future growth
Earnings Release Q1 2025
2025-04-30 English
Navamedic ASA: Imdur® distribution agreement extended to 2032
Regulatory Filings
2025-04-29 English
Navamedic ASA: Conclusion received from the Norwegian Financial Supervisory Authority
Audit Report / Information FY 2024
2025-04-28 English
Navamedic ASA: Invitation to 2025 1st quarter presentation
Report Publication Announcement
2025-04-28 English
Navamedic ASA: Navamedic has entered into an agreement in principle with Observe Medical ASA to reduce the loan receivable by 50%
Capital/Financing Update
2025-04-10 English
Navamedic Welcomes CHMP's Positive Review of Mysimba's Cardiovascular Safety
Regulatory Filings
2025-04-01 English
Navamedic ASA: Letter received from the Norwegian Financial Supervisory Authority
Legal Proceedings Report
2025-03-28 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing
2025-03-19 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing
2025-03-19 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing
2025-03-10 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing
2025-03-10 English
Flaggemelding Navamedic (NAVA)
Major Shareholding Notification
2025-02-28 Norwegian
Navamedic ASA: Mandatory notice of trade
Director's Dealing
2025-02-14 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing
2025-02-14 English
Navamedic Q4 og 2024: Et år med stabil utvikling og investeringer for videre vekst
Interim / Quarterly Report Q4 2024
2025-02-12 English
Navamedic Q4 og 2024: Et år med stabil utvikling og investeringer for videre vekst
Earnings Release Q4 2024
2025-02-12 Norwegian
Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives
Interim / Quarterly Report Q4 2024
2025-02-12 English
Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives
Earnings Release Q4 2024
2025-02-12 English
Navamedic ASA: Invitation to 2024 4th quarter presentation
Report Publication Announcement
2025-02-10 English